AXON

TransDigm (TDG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.

Baron SMID Cap ETF returned -2.87% (NAV) in the third quarter, outperforming its benchmark, the Russell 2500 Growth Index, which returned -10.35%. Read more here.

Axon commands a premium valuation despite slower profit margins, while Monday.com trades at a discount with stronger cash generation, a key divergence for long-term investors.

Get a deeper insight into the potential performance of Axon (AXON) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.

Key TakeawaysAxon fell 19% over three months to $428, now 42% below its 52-week high, even after raising 2026 revenue growth guidance to 32% to 34%. A $1.

Axon Enterprise recently launched Axon Body 5 and Axon Body 5 Pro body cameras with 25x more AI processing power, improved video and connectivity, longer battery life, and new Guardian safety features such as escalation detection and approach alerts integrated with Axon Fusus. The focus on AI rich, field based tools like Draft One, Axon Assistant, and Guardian indicates that Axon Enterprise is pus

ServiceNow commands a 20-point earnings valuation advantage, while Axon's cloud software transition masks heavy stock-based compensation.